메뉴 건너뛰기




Volumn 27, Issue SUPPL. 1, 2009, Pages 82-87

Cardioembolic stroke: Call for a multidisciplinary approach

Author keywords

Angiotensin converse enzyme inhibitors; Angiotensin receptor blockers; Anticoagulation therapy; Atrial fibrillation; Cardioembolic stroke; Rate control

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; C REACTIVE PROTEIN; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLECAINIDE; MOLECULAR MARKER; PLACEBO; PROPAFENONE; VERAPAMIL; WARFARIN;

EID: 64149087118     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000200444     Document Type: Conference Paper
Times cited : (10)

References (23)
  • 1
    • 0025764541 scopus 로고
    • Cardiac sources of embolism and cerebral infarction. Clinical consequences and vascular concomitants: The Lausanne Stroke Registry
    • Bougousslavsky J, Cachin C, Regli F, Des-pland PA, Van Melle G, Kappenberger L: Cardiac sources of embolism and cerebral infarction. Clinical consequences and vascular concomitants: The Lausanne Stroke Registry. Neurolog y 1991; 41: 855-959.
    • (1991) Neurolog y , vol.41 , pp. 855-959
    • Bougousslavsky, J.1    Cachin, C.2    Regli, F.3    Des-pland, P.A.4    Van Melle, G.5    Kappenberger, L.6
  • 2
    • 0024380805 scopus 로고
    • Cardiogenic brain embolism
    • Cerebral Embolism Task Force
    • Cerebral Embolism Task Force: Cardiogenic brain embolism. Arch Neurol 1989; 46: 727-743.
    • (1989) Arch Neurol , vol.46 , pp. 727-743
  • 6
    • 64149122764 scopus 로고    scopus 로고
    • Cavidades izquierdas
    • ed, Ecocardiografía. Madrid, Edicomplet
    • Rodriguez Padial L: Cavidades izquierdas; in Rodriguez Padial L (ed): Ecocardiografía. Madrid, Edicomplet, 2006, pp 121-144.
    • (2006) Rodriguez Padial L , pp. 121-144
    • Rodriguez Padial, L.1
  • 7
    • 85120091953 scopus 로고    scopus 로고
    • Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al: ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation - Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006; 48:854-906.
    • Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al: ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation - Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006; 48:854-906.
  • 8
    • 41949101550 scopus 로고    scopus 로고
    • Ruiz M, Romo E, Mesa D, Delgado M, An-guita M, López A, et al: Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS2 en una población mediterránea. Rev Esp Cardiol 20 08; 61: 29-35.
    • Ruiz M, Romo E, Mesa D, Delgado M, An-guita M, López A, et al: Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS2 en una población mediterránea. Rev Esp Cardiol 20 08; 61: 29-35.
  • 9
    • 39149084073 scopus 로고    scopus 로고
    • ATRIA Study Group: Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
    • Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE; ATRIA Study Group: Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 2008; 51: 810-815.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 810-815
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3    Borowsky, L.4    Pomernacki, N.K.5    Singer, D.E.6
  • 10
    • 33947307931 scopus 로고    scopus 로고
    • SPORTIF Investigators: Effect of hypertension on anticoag-ulated patients with atrial fibrillation
    • Lip GY, Frison L, Grind M; SPORTIF Investigators: Effect of hypertension on anticoag-ulated patients with atrial fibrillation. Eur Heart J 2007; 28:752-759.
    • (2007) Eur Heart J , vol.28 , pp. 752-759
    • Lip, G.Y.1    Frison, L.2    Grind, M.3
  • 11
    • 20044369896 scopus 로고    scopus 로고
    • Wachtell K, Letho M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End point in hypertension (LIFE) study. J Am Coll Cardiol 20 05; 45: 712-719.
    • Wachtell K, Letho M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End point in hypertension (LIFE) study. J Am Coll Cardiol 20 05; 45: 712-719.
  • 12
    • 20444477986 scopus 로고    scopus 로고
    • AFFIRM Investigators: Are transthoracic echocardio-graphic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
    • Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, et al; AFFIRM Investigators: Are transthoracic echocardio-graphic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 2005; 45:2026-2033.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 2026-2033
    • Olshansky, B.1    Heller, E.N.2    Mitchell, L.B.3    Chandler, M.4    Slater, W.5    Green, M.6
  • 13
    • 11144263977 scopus 로고    scopus 로고
    • Atrial fibrillation: A perspective: thinking inside and outside the box
    • Wyse DG, Gersh BJ: Atrial fibrillation: a perspective: thinking inside and outside the box. Circulation 2004; 109:3089-3095.
    • (2004) Circulation , vol.109 , pp. 3089-3095
    • Wyse, D.G.1    Gersh, B.J.2
  • 14
    • 3042565157 scopus 로고    scopus 로고
    • Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation
    • Dernellis J, Panaretou M: Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004; 25: 1100-1107.
    • (2004) Eur Heart J , vol.25 , pp. 1100-1107
    • Dernellis, J.1    Panaretou, M.2
  • 15
    • 0344861847 scopus 로고    scopus 로고
    • Anticoagula-tion therapy for stroke prevention in atrial fibrillation: How well randomized trials translate into clinical practice?
    • Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, et al: Anticoagula-tion therapy for stroke prevention in atrial fibrillation: how well randomized trials translate into clinical practice? JAMA 2003; 290: 2685-2692.
    • (2003) JAMA , vol.290 , pp. 2685-2692
    • Go, A.S.1    Hylek, E.M.2    Chang, Y.3    Phillips, K.A.4    Henault, L.E.5    Capra, A.M.6
  • 16
    • 0037028022 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with atrial fibrillation
    • The AFFIRM Investigators
    • The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
    • (2002) N Engl J Med , vol.347 , pp. 1825-1833
  • 17
    • 1842434297 scopus 로고    scopus 로고
    • Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
    • The AFFIRM Investigators
    • The AFFIRM Investigators: Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004; 109: 1509-1513.
    • (2004) Circulation , vol.109 , pp. 1509-1513
  • 18
    • 33947323278 scopus 로고    scopus 로고
    • RACE Investigators: Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial f ibrillation in hypertensives: data of the RACE study
    • Rienstra M, Van Veldhuisen DJ, Crijns HJG, Van Gelder IC; RACE Investigators: Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial f ibrillation in hypertensives: data of the RACE study. Eur Heart J 2007; 28: 741-751.
    • (2007) Eur Heart J , vol.28 , pp. 741-751
    • Rienstra, M.1    Van Veldhuisen, D.J.2    Crijns, H.J.G.3    Van Gelder, I.C.4
  • 19
    • 20544432236 scopus 로고    scopus 로고
    • Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation
    • Falk RH: Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation. Circulation 2005; 11 : 3141-3157.
    • (2005) Circulation , vol.11 , pp. 3141-3157
    • Falk, R.H.1
  • 20
    • 33748087086 scopus 로고    scopus 로고
    • Prospective randomized study comparing amiodarone vs. amiodarone plus losar-tan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation
    • Yin Y, Dalal D, Liu Z, Wu J, Liu D, Lan X, et al: Prospective randomized study comparing amiodarone vs. amiodarone plus losar-tan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. Eur Heart J 2006; 27: 1841-1846.
    • (2006) Eur Heart J , vol.27 , pp. 1841-1846
    • Yin, Y.1    Dalal, D.2    Liu, Z.3    Wu, J.4    Liu, D.5    Lan, X.6
  • 21
    • 20344396863 scopus 로고    scopus 로고
    • Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis
    • Healy JS, Baranchuck A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al: Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45: 1832-1839.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1832-1839
    • Healy, J.S.1    Baranchuck, A.2    Crystal, E.3    Morillo, C.A.4    Garfinkle, M.5    Yusuf, S.6
  • 22
    • 1842295207 scopus 로고    scopus 로고
    • Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, et al: Ventricular dysfunction and the risk of stroke after myo-cardial infa rction. N Eng l J Med 1997; 336: 251-257.
    • Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, et al: Ventricular dysfunction and the risk of stroke after myo-cardial infa rction. N Eng l J Med 1997; 336: 251-257.
  • 23
    • 0033545829 scopus 로고    scopus 로고
    • Stroke in patients with acute coronary syndromes: Incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integri-lin therapy (PURSUIT) trial
    • Mahaffey KW, Harrington RA, Simoons ML, Granger CB, Graffagnino C, Alberts MJ, et al: Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integri-lin therapy (PURSUIT) trial. Circulation 1999; 99:2371-2377.
    • (1999) Circulation , vol.99 , pp. 2371-2377
    • Mahaffey, K.W.1    Harrington, R.A.2    Simoons, M.L.3    Granger, C.B.4    Graffagnino, C.5    Alberts, M.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.